Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with the trial currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Cutaneous Squamous Cell Carcinoma
• Diffuse Large B-cell Lymphoma
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Hodgkin Lymphoma
• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• IMT-009

Snippet

Sponsor: Immunitas Therapeutics | Conditions: Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING